Manufacturing FDA imposes import alert on Indian plant after inspectors flag GMP failings BioSpaceOfficials sanctioned Dabur India months after FDA inspectors found bird droppings and data integrity deficiencies during an inspection of the plant.Read full story pharminent June 12, 2026 (Last updated: June 17, 2026) BioSpace Officials sanctioned Dabur India months after FDA inspectors found bird droppings and data integrity deficiencies during an inspection of the plant. Read full story Post navigation Previous: Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy winNext: Next Post Related Stories Manufacturing Samsung Biologics inks $262M manufacturing deal with European pharma company pharminent September 11, 2026 Manufacturing Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision pharminent September 9, 2026 Manufacturing US puts $125m into personalised RNA therapy production pharminent September 2, 2026